SCHEMBL6175495

SCHEMBL6175495

CNS(=O)(=O)Nc1cnccc1CC1(C)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.36
GAA P10253 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CCR9 P51686 3/20 0.35
POLB P06746 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
AR P10275 3/20 0.33
MAPT P10636 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
NAMPT P43490 2/20 0.32
FLT1 P17948 2/20 0.32
KDR P35968 2/20 0.32
MMP12 P39900 1/20 0.32
MMP13 P45452 1/20 0.32
MMP14 P50281 1/20 0.32
PTGS1 P23219 1/20 0.31
PTGS2 P35354 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6177182 0.90 ALDH1A1 (0.36) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173183 0.89 CYP3A4 (0.39) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173098 0.89 FLT1 (0.36) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6207150 0.87 CCR9 (0.44) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174555 0.87 IGF1R (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6172456 0.86 IGF1R (0.42) AR
SCHEMBL6224943 0.86 CCR9 (0.46) CYP2C9CCR9MAPTNAMPTKMT2A
SCHEMBL6173837 0.86 LIPE (0.38) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173294 0.86 CYP3A4 (0.38) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6172191 0.85 AOC1 (0.38) CYP3A4GAACYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed